Cognoa

Cognoa

医院和医疗保健

Palo Alto,California 6,949 位关注者

We innovate solutions for early, equitable diagnosis and care of children with developmental concerns.

关于我们

Cognoa innovates solutions for child developmental health. We build breakthrough products like Canvas Dx, the first and only FDA authorized autism diagnostic for children ages 1.5 to 6 years that uses responsible AI to empower doctors to quickly, accurately, and fairly diagnose developmental risk without bias. Our digital solutions are child centric and designed to find, assess, and treat developmental concerns early, within the time windows that will yield the optimal outcomes. Our proprietary "whole child" approach to AI fuels our pipeline of diagnostic and therapeutic products for autism, speech and language, ADHD, childhood anxiety, and more. For more information, visit www.cognoa.com.

网站
https://cognoa.com/
所属行业
医院和医疗保健
规模
11-50 人
总部
Palo Alto,California
类型
私人持股
创立
2013
领域
Machine Learning、Medtech、Med Device、Diagnostics、Healthtech、AI、Behavioral Health、Early Childhood Developmental Health、Early Childhood Development、Developmental Health、Mental Health、Digital Health、Digital Diagnostics、Early Intervention、Pediatrics、Pediatric Mental Health、Pediatric Behavioral Health、AI Healthcare和Autism

地点

  • 主要

    2185 Park Blvd

    US,California,Palo Alto,94306

    获取路线

Cognoa员工

动态

相似主页

查看职位

融资

Cognoa 共 5 轮

上一轮

B 轮

US$73,100,000.00

Crunchbase 上查看更多信息